SCHEMBL16388751

SCHEMBL16388751

Oc1cccc2ccc(Nc3ccc(OC(F)(F)F)cc3)nc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.54
HTT P42858 3/20 0.49
RAB9A P51151 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 2/20 0.49
KDM4E B2RXH2 2/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
ALOX12 P18054 1/20 0.49
KLF5 Q13887 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 4/20 0.45
MEN1 O00255 2/20 0.45
KCNH2 Q12809 1/20 0.44
SCN5A Q14524 1/20 0.44
SCN9A Q15858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19380740 0.85 DHFR (0.55) DHFRHTTRAB9AKMT2ASMN1; SMN2
SCHEMBL1706290 0.85 DHFR (0.55) DHFRHTTRAB9AKMT2ASMN1; SMN2
Obefazimod SCHEMBL1705888 0.84 DHFR (0.54) DHFRHTTRAB9AKMT2ASMN1; SMN2
SCHEMBL1702468 0.84 DHFR (0.58) DHFRRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1705361 0.84 DHFR (0.54) DHFRHTTRAB9AKMT2ASMN1; SMN2
Obefazimod SCHEMBL30729382 0.83 DHFR (0.53) DHFRHTTRAB9AKMT2ASMN1; SMN2
Obefazimod SCHEMBL29157012 0.83 DHFR (0.53) DHFRHTTRAB9AKMT2ASMN1; SMN2
SCHEMBL18034847 0.82 DHFR (0.52) DHFRHTTRAB9AKMT2ASMN1; SMN2
SCHEMBL1702461 0.82 DHFR (0.53) DHFRRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL7116183 0.81 KDM4E (0.55) DHFRHTTRAB9AKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015001518-A1 BICYCLIC COMPOUNDS USEFUL FOR TREATING DISEASES CAUSED BY RETROVIRUSES SPLICOS (FR) 2015-01-08 WO disclosed